We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.36%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$46.8B
AUM Growth
-$2.48B
Cap. Flow
-$831M
Cap. Flow %
-1.77%
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$130M
2
AMGN icon
Amgen
AMGN
+$96.1M
3
PGR icon
Progressive
PGR
+$94.9M
4
ABBV icon
AbbVie
ABBV
+$77.1M
5
KVUE icon
Kenvue
KVUE
+$75.6M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$148M
2
JNJ icon
Johnson & Johnson
JNJ
+$147M
3
LYB icon
LyondellBasell Industries
LYB
+$108M
4
DG icon
Dollar General
DG
+$91.2M
5
XOM icon
ExxonMobil
XOM
+$87.6M

Sector Composition

Rank Sector Weight
1 Technology 24.48%
2 Healthcare 17.42%
3 Financials 12.53%
4 Consumer Discretionary 9.71%
5 Communication Services 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADT icon
1626
ADT
ADT
$5.34B
$432K ﹤0.01%
72,050
NEO icon
1627
NeoGenomics
NEO
$1.73B
$432K ﹤0.01%
35,100
BATRA icon
1628
Atlanta Braves Holdings Series A
BATRA
$3.56B
$430K ﹤0.01%
11,010
TILE icon
1629
Interface
TILE
$2B
$428K ﹤0.01%
43,674
ACMR icon
1630
ACM Research
ACMR
$4.92B
$428K ﹤0.01%
23,660
MODN
1631
DELISTED
MODEL N, INC.
MODN
$428K ﹤0.01%
17,540
RYTM icon
1632
Rhythm Pharmaceuticals
RYTM
$7.44B
$425K ﹤0.01%
18,550
+2,350
+15% +$52.6K
LOVE icon
1633
LoveSac
LOVE
$253M
$425K ﹤0.01%
+21,315
New +$526K
RVNC
1634
DELISTED
Revance Therapeutics, Inc.
RVNC
$424K ﹤0.01%
37,000
PI icon
1635
Impinj
PI
$3.88B
$421K ﹤0.01%
7,650
HCSG icon
1636
Healthcare Services Group
HCSG
$1.57B
$418K ﹤0.01%
40,062
-1,049,375
-96% -$13.1M
DCH
1637
Dauch Corp
DCH
$1.32B
$417K ﹤0.01%
57,400
PHR icon
1638
Phreesia
PHR
$661M
$414K ﹤0.01%
22,140
HE icon
1639
Hawaiian Electric Industries
HE
$2.3B
$413K ﹤0.01%
33,589
ECPG icon
1640
Encore Capital Group
ECPG
$2.08B
$412K ﹤0.01%
8,623
TAL icon
1641
TAL Education Group
TAL
$5.79B
$409K ﹤0.01%
44,950
NUS icon
1642
Nu Skin
NUS
$257M
$408K ﹤0.01%
19,250
NPK icon
1643
National Presto Industries
NPK
$893M
$406K ﹤0.01%
5,600
SCSC icon
1644
Scansource
SCSC
$1.14B
$405K ﹤0.01%
13,352
VSAT icon
1645
Viasat
VSAT
$9.67B
$405K ﹤0.01%
21,923
TRUP icon
1646
Trupanion
TRUP
$1.12B
$398K ﹤0.01%
14,120
USNA icon
1647
Usana Health Sciences
USNA
$429M
$397K ﹤0.01%
6,770
IMA
1648
ImageneBio Inc
IMA
$63.7M
$391K ﹤0.01%
7,526
ONL
1649
Orion Office REIT
ONL
$148M
$389K ﹤0.01%
74,657
+9,800
+15% +$59.5K
HRMY icon
1650
Harmony Biosciences
HRMY
$2.1B
$384K ﹤0.01%
11,710

Similar funds

Ensign Peak Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Ensign Peak Advisors held 1,786 positions worth $46.8B, down 5% from $49.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 3.1%. Ensign Peak Advisors opened 25 new positions and exited 30, leaving the 1,786-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q3 2023 buy was Invesco QQQ Trust: 160,000 shares worth $57.3M.
  • Ensign Peak Advisors added most to Crown Castle in Q3 2023, an estimated $130M increase.
  • Ensign Peak Advisors's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $148M.
  • Ensign Peak Advisors fully exited RB Global in Q3 2023, selling an estimated $26.5M.
  • Ensign Peak Advisors's ten largest holdings make up 28% of its $46.8B portfolio in Q3 2023.
  • Ensign Peak Advisors opened 25 new positions and closed 30 in Q3 2023.
  • Ensign Peak Advisors's portfolio value fell 5% quarter-over-quarter to $46.8B.

Based on Ensign Peak Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.